| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-86683 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47743-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47737-0.1mg | |||
| IHC-Prediluted | NBP2-48462 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26618-50ul | |||
![Immunohistochemistry-Paraffin: c-Myc Antibody (MYC909) - IHC-Prediluted [NBP2-48090] - Human Cervical Carcinoma stained with c-myc Monoclonal Antibody (MYC909).](http://images.novusbio.com/fullsize/c-Myc-Antibody-MYC909-IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-48090-img0001.jpg "Immunohistochemistry-Paraffin: c-Myc Antibody (MYC909) - IHC-Prediluted [NBP2-48090] - Human Cervical Carcinoma stained with c-myc Monoclonal Antibody (MYC909).")
![Western Blot: ER alpha/NR3A1 Antibody (ER505) - Azide and BSA Free [NBP2-33106] - Western blot analysis of Estrogen Receptor in MCF-7 lysate using Estrogen Receptor Ab (ER505).](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-ER505-Azide-and-BSA-Free-Western-Blot-NBP2-33106-img0003.jpg "Western Blot: ER alpha/NR3A1 Antibody (ER505) - Azide and BSA Free [NBP2-33106] - Western blot analysis of Estrogen Receptor in MCF-7 lysate using Estrogen Receptor Ab (ER505).")
![Immunohistochemistry-Paraffin: EGFR Antibody (31G7 + GFR1195) - IHC-Prediluted [NBP2-48218] - Formalin-fixed, paraffin-embedded human Placenta stained with EGFR Monoclonal Antibody (31G7 + GFR1195).](http://images.novusbio.com/fullsize/EGFR-Antibody-31G7-+-GFR1195-IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-48218-img0001.jpg "Immunohistochemistry-Paraffin: EGFR Antibody (31G7 + GFR1195) - IHC-Prediluted [NBP2-48218] - Formalin-fixed, paraffin-embedded human Placenta stained with EGFR Monoclonal Antibody (31G7 + GFR1195).")
![Immunohistochemistry-Paraffin: FGF-9 Antibody (E4) [NBP3-41128] - DAB staining on IHC-P; Sample: Human Stomach Tissue; Primary Ab: 20ug/ml NBP3-41128; Second Ab: 2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41128_mouse-fgf-9-mab-e4-6122024212729.jpg "Immunohistochemistry-Paraffin: FGF-9 Antibody (E4) [NBP3-41128] - DAB staining on IHC-P; Sample: Human Stomach Tissue; Primary Ab: 20ug/ml NBP3-41128; Second Ab: 2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody")
![Immunohistochemistry-Paraffin: TGF-alpha Antibody (TGFA/1119) [NBP2-45142] - Human Testicular Carcinoma stained with TGF alpha Monoclonal Antibody (TGFA/1119)](http://images.novusbio.com/fullsize/TGF-alpha-Antibody-TGFA-1119-Immunohistochemistry-Paraffin-NBP2-45142-img0001.jpg "Immunohistochemistry-Paraffin: TGF-alpha Antibody (TGFA/1119) [NBP2-45142] - Human Testicular Carcinoma stained with TGF alpha Monoclonal Antibody (TGFA/1119)")
![ELISA: DLL3 Antibody (7B7) [NBP3-26618] - The Binding Activity of DLL3 with DLL3 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 ug/mL can bind DLL3 Antibody, the EC50 is 1.625-2.702 ng/mL.](http://images.novusbio.com/fullsize/nbp3-26618_human-dll3-mab-7b7-262202412272346.jpg "ELISA: DLL3 Antibody (7B7) [NBP3-26618] - The Binding Activity of DLL3 with DLL3 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 ug/mL can bind DLL3 Antibody, the EC50 is 1.625-2.702 ng/mL.")
![ELISA: DLL3 Antibody (7B7) [NBP3-26618] - The Binding Activity of DLL3 with DLL3 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 ug/mL can bind DLL3 Antibody, the EC50 is 1.102-1.707 ng/mL.](http://images.novusbio.com/fullsize/nbp3-26618_human-dll3-mab-7b7-262202412272316.jpg)
![Flow Cytometry: DLL3 Antibody (7B7) [NBP3-26618] - Untransfected HEK293 cells (green line) and transfected Human DLL3 HEK293 stable cells (red line) were stained with anti-DLL3 antibody (rovalpituzumab-like) (2ul/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG1 Fc antibody and analyzed with flow cytometry.](http://images.novusbio.com/fullsize/nbp3-26618_human-dll3-mab-7b7-282202414312733.jpg)